ES2723248T3 - Limonoides de tipo fragmalina para el tratamiento de disfunción sexual - Google Patents

Limonoides de tipo fragmalina para el tratamiento de disfunción sexual Download PDF

Info

Publication number
ES2723248T3
ES2723248T3 ES13702766T ES13702766T ES2723248T3 ES 2723248 T3 ES2723248 T3 ES 2723248T3 ES 13702766 T ES13702766 T ES 13702766T ES 13702766 T ES13702766 T ES 13702766T ES 2723248 T3 ES2723248 T3 ES 2723248T3
Authority
ES
Spain
Prior art keywords
preferred
hydrogen
methyl
acetyloxy
oxoethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13702766T
Other languages
English (en)
Spanish (es)
Inventor
Jarl Wikberg
Aigars Jirgensons
Edvards Liepinsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dicot AB
Original Assignee
Dicot AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dicot AB filed Critical Dicot AB
Application granted granted Critical
Publication of ES2723248T3 publication Critical patent/ES2723248T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
ES13702766T 2012-01-25 2013-01-25 Limonoides de tipo fragmalina para el tratamiento de disfunción sexual Active ES2723248T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE1200052 2012-01-25
SE1200678 2012-11-06
SE1300011 2013-01-04
PCT/EP2013/051413 WO2013110744A2 (en) 2012-01-25 2013-01-25 Novel compounds, their manufacture and uses (ii)

Publications (1)

Publication Number Publication Date
ES2723248T3 true ES2723248T3 (es) 2019-08-22

Family

ID=47666104

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13702766T Active ES2723248T3 (es) 2012-01-25 2013-01-25 Limonoides de tipo fragmalina para el tratamiento de disfunción sexual

Country Status (11)

Country Link
US (1) US9403841B2 (enExample)
EP (1) EP2807170B1 (enExample)
CN (1) CN104254537B (enExample)
AU (1) AU2013213580B2 (enExample)
CA (1) CA2861045A1 (enExample)
DK (1) DK2807170T3 (enExample)
ES (1) ES2723248T3 (enExample)
IN (1) IN2014DN05615A (enExample)
NZ (1) NZ626736A (enExample)
PL (1) PL2807170T3 (enExample)
WO (1) WO2013110744A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104628692B (zh) * 2015-02-09 2016-02-10 庄爱华 柠檬苦素类化合物，其药物组合物及其制备方法和用途
CN208336488U (zh) * 2015-07-31 2019-01-04 株式会社村田制作所 线圈天线以及天线装置
CN109394732A (zh) * 2017-08-16 2019-03-01 安徽中医药大学 盐酸青藤碱肠溶定位渗透泵控释胶囊及其制备方法
CN110903912B (zh) * 2019-11-29 2022-01-28 华东理工大学 一种芳基油脂及其制备方法与应用
CN111755072B (zh) * 2020-08-04 2021-02-02 深圳吉因加医学检验实验室 一种同时检测甲基化水平、基因组变异和插入片段的方法及装置
CN112898263B (zh) * 2021-01-28 2022-03-08 江西中医药大学 一种从佛手中分离的香豆素骈木脂素化合物及其保肝用途
SE2251130A1 (en) * 2022-09-30 2024-03-31 Dicot Ab New compounds and methods of their manufacturing
WO2025040810A1 (en) 2023-08-23 2025-02-27 Dicot Pharma Ab Therapeutic compounds, a method of manufacturing thereof as well as uses thereof
WO2025141142A1 (en) * 2023-12-29 2025-07-03 Dicot Pharma Ab A novel method for recovering limonoid compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1318825A2 (de) 2000-07-26 2003-06-18 Vitaplant AG Piper methysticum pflanzenextrakt
CN1226298C (zh) * 2003-08-07 2005-11-09 中国科学院南海海洋研究所 柠檬苦素化合物－木果楝内酯及其用途
JP2005213202A (ja) 2004-01-29 2005-08-11 Maruzen Pharmaceut Co Ltd 抗酸化剤、抗老化剤及び抗炎症剤、並びに、皮膚化粧料
CA2623831A1 (en) 2005-09-12 2007-03-22 Council Of Scientific And Industrial Research An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia
AU2008256521B2 (en) 2007-05-29 2014-09-04 Dicot Ab Novel compounds and pharmaceutical preparations from Neobeguea spec
GB0710230D0 (en) 2007-05-30 2007-07-11 Reckitt Benckiser Nv Detergent dosing device
US7786171B2 (en) 2008-04-04 2010-08-31 Abbott Laboratories Amide derivatives as positive allosteric modulators and methods of use thereof

Also Published As

Publication number Publication date
AU2013213580B2 (en) 2017-06-15
EP2807170A2 (en) 2014-12-03
NZ626736A (en) 2016-11-25
CA2861045A1 (en) 2013-08-01
DK2807170T3 (da) 2019-05-27
AU2013213580A1 (en) 2014-07-24
EP2807170B1 (en) 2019-03-13
US20150011616A1 (en) 2015-01-08
IN2014DN05615A (enExample) 2015-04-03
PL2807170T3 (pl) 2019-09-30
CN104254537A (zh) 2014-12-31
WO2013110744A2 (en) 2013-08-01
CN104254537B (zh) 2017-06-30
HK1204325A1 (en) 2015-11-13
WO2013110744A3 (en) 2013-10-31
US9403841B2 (en) 2016-08-02

Similar Documents

Publication Publication Date Title
ES2723248T3 (es) Limonoides de tipo fragmalina para el tratamiento de disfunción sexual
AR092269A1 (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
AR087184A1 (es) Derivados de azaindol utiles para tratar infecciones por hiv y composiciones farmaceuticas que los contienen
AR092955A1 (es) Antagonistas de receptores de orexina los cuales son derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona
AR070395A1 (es) Derivados de 4,5-dihidro-oxazol-2-il- amina
Hegab et al. Synthesis, X‐ray Structure, and Pharmacological Activity of Some 6, 6‐disubstituted Chromeno [4, 3‐b]‐and Chromeno‐[3, 4‐c]‐quinolines
AR086792A1 (es) Compuestos para el tratamiento de la adiccion
AR088441A1 (es) Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales
UY35641A (es) PROCEDIMIENTO DE SÍNTESIS PARA PREPARAR ANÁLOGOS MACROCÍCLICOS C1-CETO DE HALICONDRINA B, E INTERMEDIARIOS ÚTILES INCLUYENDO INTERMEDIARIOS CONTENIENDO GRUPOS ?SO2-(p-TOLILO)
CO6761397A2 (es) Métodos para preparar glicoesfingolípidos y usos de los mismos
AR093659A1 (es) Derivados ciclicos de nucleosidos y usos de los mismos
ES2421453T3 (es) Derivados de tiofenocarboxamida como ligandos del receptor EP4
RU2017123878A (ru) Пиколинамидные соединения с фунгицидной активностью
PE20110409A1 (es) Compuestos heterociclicos antiviricos
PE20160844A1 (es) Compuestos triciclicos como agentes anticancerigenos
AR076579A1 (es) Espironucleosidos uracilicos oxetanicos, composiciones farmaceuticas que los contienen y uso de los mismos como inhibidores del virus de la hepatitis c (vhc).
AR095427A1 (es) Compuestos aromáticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepática, la fibrosis de la piel y la fibrosis cardíaca
CO6300938A2 (es) Derivados de (3as, 4s, 5r, 7s, 7ar)-2-[((1r, 2r)-2-{[4-(1,2-benzisotiazol-3-il)piperazin-1-il]metil}ciclohexil) metil]-5,5-disubstituido-hexahidro-1h-4,7-metanoisoindol-1,3-dionas, utiles en el tratamiento de desordenes neurologicos y psiquiatricos
AR078321A1 (es) Derivados de 2,4'-bipiridina como inhibidores de cinasa (cdk9)
DOP2014000286A (es) Compuestos de acido dimetil-benzoico
ECSP099441A (es) Nuevos intermediarios y procesos útiles en la preparación de {2-[1-(3,5-bis-trifluorometil-bencil)-5-piridin-4-il-1h-[1,2,3]triazol-4-il]-piridin-3-il}-(2-clorofenil)-metanona
AR098522A1 (es) Compuesto de triazolo-piridina
AR110977A2 (es) Compuestos de cicloalquiloxi- y heterocicloalquiloxipiridina como moduladores del receptor de histamina h₃
AR093408A1 (es) Derivados de oxazolidin-2-ona-pirimidina
JP2019524674A5 (enExample)